A new antibody developed by AstraZeneca has received emergency use approval in the US, according to the company's chief medical officer, Dr. John Wright, who has been involved in testing the virus for the first time since the start of the pandemic.
Source: wallstreet-online.dePublished on 2021-12-09
Related news
- telangana : Telangana govt explores deals with France | Hyderabad News
- ACT - IAC Accelerating Government Episode 5 : CX and Tech Spotlight
- European Equities : Economic Data from China , the Eurozone , and the U . S in Focus
- 1950 Census Release Will Offer Enhanced Digital Access , Public Collaboration Opportunity
- National Archives Releases Catalog , 1940 Census Datasets
- INTRUSION Appoints Renowned Cybersecurity Expert , Tony Scott , as New President & CEO
- 1950 Census Records
- Emerging technology gives first ever global view of hidden vessels
- Molecular Partners Confirms Retained Activity of Ensovibep on the Positions Mutated in Emerging Omicron Variant of SARS - CoV - 2 In Vitro
- European Equities : German Industrial Production and China in Focus
- Molecular Partners Present Data Demonstrating Successful Inhibition of COVID19 Viral Variants with Ensovibep at the 2021 ISIRV - WHO Conference
- Explore 1950 Census Resources on New Archives . gov Page
- Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
- Hasura Announces Schedule for Third Annual GraphQL Asia Conference
- Kandy Joins Project CAMARA - The Telco Global API Alliance